Message boards index | Help | Search messages | Sign in


+ UKCAB + Public area + News, events, announcments + HIV Treatment study:gift voucher worth 20 for Amazon.

HIV Treatment study:gift voucher worth 20 for Amazon.

Print
Pages: 1

Elias Phiri
Member
Posts: 90
HIV Treatment study:gift voucher worth 20 for Amazon.
Posted on: November 27 2013, 11:24 am

FYI Dear colleagues,
 
You are invited to take part in a HIV Treatment study which will simply involve you completing a questionnaire about HIV treatment choices using a web-based survey. If you are not eligible to complete this survey please pass the message to your colleagues who may qualify to complete the survey. The survey does not collect personal details just your views. Upon completion of the survey, you will receive an online gift voucher worth 20 for Amazon.

If you have completed the survey and you have not received the gift voucher, please contact Elias on 07459304972. Should you have any questions regarding this survey, please contact Opinion Health on  info@opinionhealth.com or by calling 020 3031 8317. For more information about the study- see info below.
 
If you are interesting in taking part please click on the link below:
To the questionnaire: http://survey.opinionhealth.co.uk/uc/6105live/?a=1&b=100

-----------------------------
About the study:
Dear Sir/Madam,

This research is designed to understand which factors associated with HIV treatments are of the greatest importance to patients.

As you are probably aware, there are a large number of drugs and drug combinations available for HIV. Many of the available HIV drugs have problems associated with them including side effects, long-term health problems, burdensome pill regimes and some must be taken with or without food to maximise their effectiveness. All of these attributes can be seen as a burden on patients and can affect how well patients adhere to their medication. This has been shown to be a problem in HIV treatment, where successful treatment depends upon patients taking their medication regularly and at the correct time each day.

Many of these attributes have been reported previously in the literature, but little is known about which of these factors are most important to patients. This is particularly important as people living with HIV often take medication for many years and play a large part in making decisions about which medication to take, along with their physician. Being able to identify which of these factors are of greatest importance to patients will aid physicians when making treatment decisions and influence the design of new HIV treatments. It has been previously reported that physicians do not share the same views about the severity of treatment side effects and impact on quality of life as patients. If treatments are selected for patients in accordance with their preferences, this could lead to increased medication adherence and better disease outcomes.

The study in the UK is part of a larger study that will involve interviews with patients and clinicians and it is being conducted in 5 European countries. Results from this study will be presented in national conferences and submitted for publication in clinical journals in the UK, as well as international conferences and peer-reviewed publications along with results from the other study sites in Germany, France, Spain, and Italy.

This research is divided into two stages: The first stage has already been completed, which involved qualitative interviews with a small number of HIV patients. During the interview, descriptions of various treatment attributes were discussed with the participant in order to select the ones to be included in the second stage, as well as to identify any that are difficult to understand or could be rephrased more clearly. The second stage takes the form of a quantitative online survey with 1500 HIV patients in 5 European countries. Different combinations of treatment attributes will be presented to participating patients in order to understand on an empirical level which attributes are the most important from a patient perspective and whether this varies across countries.

The survey is not in any way promotional and can be accessed anonymously. This research is conducted according to all relevant guidelines regarding participant protection, anonymity and confidentiality. All information collected will be used for research purposes only and the research has received Institutional Review Board approval.

Should you require any further information plead feel free to contact us directly.

Kind regards
Opinion Health

--
Opinion Health
11 Poland Street
London
W1F 8QA

www.opinionhealth.com
info@opinionhealth.com
Logged
Simon Collins
Global Moderator
Posts: 651
Re: HIV Treatment study:gift voucher worth 20 for Amazon.
Reply #1 on: November 27 2013, 12:50 pm

On a quick look this is a survey for ViiV. the context is that the more data they get that supports qualities of dolutegravir, this could be used to charge a higher price for dolutegravir.

I personally dislike these surveys are the results are used to manipulate commercial decisions.

On the other hand, it looks like you get a 20 quid Amazon voucher.

S
Logged

Print
Pages: 1

+ UKCAB + Public area + News, events, announcments + HIV Treatment study:gift voucher worth 20 for Amazon.